The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA)
- 14 May 2003
- journal article
- review article
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 27 (3) , 199-217
- https://doi.org/10.1016/s0149-7634(03)00031-9
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- MDMA induced dopamine release in vivo: role of endogenous serotoninJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1997
- Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudatePharmacology Biochemistry and Behavior, 1991
- MDL72222, a serotonin 5-HT3 receptor antagonist, blocks MDMA's ability to establish a conditioned place preferencePharmacology Biochemistry and Behavior, 1991
- Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the ratPharmacology Biochemistry and Behavior, 1991
- Methylenedioxymethamphetamine's capacity to establish place preferences and modify intake of an alcoholic beveragePharmacology Biochemistry and Behavior, 1990
- Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by microdialysisLife Sciences, 1990
- Stereochemistry of the metabolism of MDMA to MDALife Sciences, 1989
- Experimental hyperphenylalaninemia in the pregnant guinea pig: Possible phenylalanine teratogenesis and p‐chlorophenylalanine embryotoxicityTeratology, 1987
- Effects of phencyclidine, ketamine and MDMA on complex operant behavior in monkeysPharmacology Biochemistry and Behavior, 1987
- Further investigation of the discriminative stimulus properties of MDAPharmacology Biochemistry and Behavior, 1984